In the first interview of 2021, we spoke with Darryl McConnell, Senior Vice President, Research Site Head, Austria, Boehringer Ingelheim.
Discussing everything from the mindset and progress seen in tackling cancers’ big 4, to highlights of an unprecedented year, Darryl shares his expert insights into the industry, it’s challenges and what’s in store for ‘undruggable’ over the coming years.
Topics covered include:
- How are Boehringer Ingelheim currently tackling “undruggable” targets?
- What is the biggest challenge facing the industry right now?
- Which moments have stood out for you in 2020, and what are you most excited for in 2021?